Dr. Joydeep Ghosh
Senior Consultant
17 years of experienceMedical Oncologists
MBBS, MD, DM
Apollo Gleneagles Medical Centre, Kolkata
Book an AppointmentAbout Dr. Joydeep Ghosh
Dr. Joydeep Ghosh is a highly skilled Medical Oncologist with 17 years of extensive professional experience. He obtained his MBBS degree from Medical Coll. and Hosp., Kolkata, in 2007. Furthering his specialization, he pursued an MD in General Medicine from the Inst. of Post-Graduate Medical Education and Research and Seth Sukhlal Karnani Memorial Hosp. (IPGMER and SSKM Hosp.) in 2011. Dr. Ghosh then pursued DM in Oncology from Tata Medical Center Mumbai in 2016, solidifying his specialization in oncology and cancer care. His specialization includes treating breast cancer, gynecological cancers, and gastrointestinal cancers. He is known for using the latest advancements in cancer treatment, such as hormone therapy, targeted therapy, and immunotherapy. Devoted to providing high-quality care, Dr. Ghosh continually updates his knowledge and skills in oncology, a rapidly evolving field. He is actively involved in research and academic pursuits, contributing to advancements in oncology and sharing his knowledge with the medical community through publications and presentations. Patients trust Dr. Ghosh for his compassionate approach, extensive expertise, and commitment to delivering personalized care tailored to each individual's needs. His professional affiliations and memberships include associations with prestigious medical societies, which reflect his dedication to staying current with the latest developments in oncology practice.Education
MBBS - Medical Coll. and Hosp., Kolkata - 2007 MD (Internal Medicine) - Inst. of Post-Graduate Medical Education and Research and Seth Sukhlal Karnani Memorial Hosp. (IPGMER and SSKM Hosp.) - 2011 DM (Medical Oncology) Tata Medical Center Mumbai - 2016Past Experience
Medical Consultant, TATA MEDICAL CENTER - 2023 DM Resident, TATA MEMORIAL Hosp. -2016 Senior Registrar, Apollo Hospitals - 2012 MD trainee, IPGMER and SSKM Hosp. - 2011Paper Published
Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma in the Era of Targeted Therapy: Scientifically Relevant or Natural Selection? Perspective of Oncology Patients During COVID-19 Pandemic: A Prospective Observational Study From India Outcome of COVID-19 in Solid Organ Malignancies: professional experience From a Tertiary Cancer Center in Eastern India 32P Clinical profile and presentation of patients with gastroenteropancreatic neuroendocrine neoplasms: An updated dataset from India Real-world professional experience with maintenance PARPi plus minus Bevacizumab in newly diagnosed advanced ovarian cancer with Germline BRCA or HRD positive Real-world study of safety and efficacy of lorlatinib as second line and beyond in ALK-rearranged advanced non-small cell lung cancer patients in India – a multicentre chart review study (ROSELAND) EP156/#642 Survival outcomes in advanced stage operable carcinoma endometrium: professional experience of surgical treatment at a tertiary care cancer center 287MO Real-world professional experience with maintenance PARP inhibitor plus minus bevacizumab in newly diagnosed advanced ovarian cancer with germline BRCA mutations or homologous recombination deficiency (HRD) positive Practice Patterns and Survival in Patients with Resected Pancreatic Ductal Adenocarcinomas (PDAC) — Results from the Multicentre Indian Pancreatic & Periampullary Adenocarcinoma Project (MIPPAP) Study 272P Correlation of dihydropyrimidine dehydrogenase gene mutation with toxicity among gastrointestinal cancers (GI) taking 5-fluorouracil-based chemotherapy: professional experience from a tertiary cancer center in the eastern part of India
Area of Expertise
- Chemotherapy
- Endometrial Biopsy
- Fine Needle Aspiration
- Hormone Therapy
- Immunotherapy
- Microsurgical Tumor Removal